Abstract

The aim of this current study is to estimate the cost-effectiveness of Alpelisib plus Fulvestrant in HR+/HER2- advanced Breast Cancer patients with a PIK3CA mutation.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
EE46 Cost-Effectiveness of Alpelisib Plus Fulvestrant in Postmenopausal Women with Hr+/HER2- Advanced Breast Cancer (ABC) in Oman
D Soliman ... S Hawkshaw
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 26
D Soliman, et. al.D Soliman ... S Hawkshaw
01 Jun 2023
PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come
Leticia De Mattos-Arruda
ESMO open | VOL. 5
Leticia De Mattos-ArrudaLeticia De Mattos-Arruda
01 Jan 2020
Abstract P2-01-18: Orthogonal assessment of PIK3CA and ESR1 mutation detection in longitudinal cfDNA samples from endocrine-resistant HR+/HER2- advanced breast cancer patients using dPCR and NGS-based SafeSEQ technology
Jesus Fuentes Antras ... Paloma Flores
American Journal of Cancer | VOL. 82
Jesus Fuentes Antras, et. al.Jesus Fuentes Antras ... Paloma Flores
15 Feb 2022
The Effect of P-Glycoprotein (P-gp), Nuclear Factor-Kappa B (Nf-κb), and Aldehyde Dehydrogenase-1 (ALDH-1) Expression on Metastases, Recurrence and Survival in Advanced Breast Cancer Patients
Yan Wisnu Prajoko ... Teguh Aryandono
Asian Pacific journal of cancer prevention : APJCP | VOL. 20
Yan Wisnu Prajoko, et. al.Yan Wisnu Prajoko ... Teguh Aryandono
01 May 2019
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
How many Monte Carlo samples are needed for probabilistic cost-effectiveness analyses?
Reza Yaesoubi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Reza YaesoubiReza Yaesoubi
06 Jul 2024
Three Pillars of Support for Orphan Drug Programs: Individual Valuations, Societal Valuations, and Anonymous Altruism
Darius N Lakdawalla ... Hong-Hanh Nguyen
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Darius N Lakdawalla, et. al.Darius N Lakdawalla ... Hong-Hanh Nguyen
06 Jul 2024
EQ-5D-5L population scores in mainland China: results from a nationally representative survey 2021
Qiang Yao ... Chaojie Liu
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Qiang Yao, et. al.Qiang Yao ... Chaojie Liu
06 Jul 2024
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
View more papers